Graves’ disease (GD) is an autoimmune disease which arises from a complex interplay of pathogenic factors, with hyperthyroidism primarily driven by autoantibodies that stimulate the thyrotropin receptor (TSH-R) on thyroid epithelial cells [1]. This evidence concerns the gene TSHR and hyperthyroidism.